Detalles de la búsqueda
1.
Cognitive enhancement drug use among future physicians: findings from a multi-institutional census of medical students.
J Gen Intern Med
; 28(8): 1028-34, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23595918
2.
The new landscape of therapy for myelofibrosis.
Curr Hematol Malig Rep
; 8(4): 325-32, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24101258
3.
Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms.
Leuk Lymphoma
; 54(10): 2226-30, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23398206
4.
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
J Clin Oncol
; 30(33): 4098-103, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23071245
5.
Ruxolitinib in clinical practice for therapy of myelofibrosis: single USA center experience following Food and Drug Administration approval.
Leuk Lymphoma
; 55(1): 195-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23647081
6.
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
J Clin Oncol
; 30: [6 p.], 2012. tab
Artículo
en Inglés
| URUCAN | ID: bcc-4476
Resultados
1 -
6
de 6
1
Próxima >
>>